Table 3.
Cancer-specific survival by bivariable Cox models of the 66 stage II small bowel adenocarcinomas
| Bivariable model | HR (95% CI) | P value (Cox) |
|---|---|---|
| Model#1 | 0.009 | |
| MMR-d | ||
| Yes | 0.24 (0.07–0.87) | 0.03 |
| No | 1 | |
| T stage | ||
| T3 | 1 | |
| T4 | 2.63 (0.97–7.11) | 0.058 |
| Model#2 | 0.004 | |
| Celiac disease | ||
| Yes | 0.12 (0.02–0.94) | 0.043 |
| No | 1 | |
| T stage | ||
| T3 | 1 | |
| T4 | 2.76 (1.02–7.45) | 0.045 |
| Model#3 | 0.001 | |
| Histologic subtype | ||
| Cohesive | 0.15 (0.05–0.45) | 0.001 |
| Non-cohesive | 1 | |
| T stage | ||
| T3 | 1 | |
| T4 | 4.16 (1.41–12.26) | 0.01 |
| Model#4 | 0.003 | |
| Celiac disease | ||
| Yes | 0.18 (0.02–1.46) | 0.109 |
| No | 1 | |
| Histologic subtype | ||
| Cohesive | 0.33 (0.12–0.90) | 0.031 |
| Non-cohesive | 1 |
CI confidence interval; MMR-d mismatch repair deficiency